HARVEY CAPITAL MANAGEMENT INC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1119032
PALM BEACH, FL
Position in REGN
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$3,102,111
-$4,605,745 QoQ
Shares Held
4,975
-50.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#454
of 1,320 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HARVEY CAPITAL MANAGEMENT INC holds $41,212,465 across 6 Biotechnology names. REGN ranks #6 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
146,113 | $11,436,264 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
138,835 | $10,340,430 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
26,913 | $6,485,225 | |
| 4 | CYTK |
Cytokinetics Inc
|
68,275 | $5,816,347 | |
| 5 | ARGX |
Argenx SE
|
4,346 | $4,032,088 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
4,975 | $3,102,111 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,102,111 | 4,975 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $7,707,856 | 9,976 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $7,871,530 | 10,198 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,411,002 | 11,402 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $6,164,550 | 11,742 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,303,339 | 13,092 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $9,305,879 | 13,064 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $13,478,999 | 12,822 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $13,513,092 | 12,857 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $12,442,108 | 12,927 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $11,421,283 | 13,004 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $10,806,287 | 13,131 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,456,704 | 13,161 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $10,336,608 | 12,580 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $9,177,352 | 12,720 | Shares | Sole | 2023-02-27 | |
| 2022-09-30 | $8,769,315 | 12,730 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,345,765 | 15,810 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $11,798,409 | 16,893 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $10,606,378 | 16,795 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $9,538,847 | 15,762 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $9,585,663 | 17,162 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $5,231,508 | 11,057 | Shares | Sole | 2021-05-07 | |
| 2020-09-30 | $223,912 | 400 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $280,642 | 450 | Shares | Sole | 2020-08-05 | |
| No filing history on record for this holder in this stock. | ||||||